Codice QR

Chemotherapy combined with regorafenib and immune checkpoint inhibitors as a first-line treatment for patients with advanced biliary tract cancer: a single arm phase II trial

ObjectiveThis study aimed to investigate the efficacy, long-term prognosis and safety of combining chemotherapy with regorafenib and immune checkpoint inhibitors as first-line treatment for patients with advanced biliary tract carcinoma (BTC).MethodsIn this single arm phase II trial, twenty-nine pat...

Descrizione completa

Salvato in:
Autori principali: Jianwei Liu, Shilei Bai, Yanfu Sun, Lei Hu, Ruiliang Ge, Feng Xue
Natura: Artigo
Lingua:Inglês
Pubblicazione: Frontiers Media S.A. 2024-09-01
Serie:Frontiers in Immunology
Soggetti:
advanced biliary tract cancer
first-line therapy
targeted therapy
immunotherapy
chemotherapy
prognosis
Accesso online:https://www.frontiersin.org/articles/10.3389/fimmu.2024.1449211/full
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne!!

Documenti analoghi